News

Market SynopsisThe Global Radiopharmaceuticals Market is valued at USD 6.8 Billion in 2024 and is projected to reach a value of USD 19.15 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...
A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.
Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...
A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...
Roche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...
A pioneering brain scanner, one of the first to be owned by an NHS trust in England, is being trialled in Kent to improve ...